v3.26.1
Commitments and Contingencies (Details)
12 Months Ended
Feb. 16, 2026
Nov. 30, 2025
USD ($)
Sep. 05, 2025
USD ($)
Dec. 13, 2024
USD ($)
Nov. 01, 2023
May 15, 2023
USD ($)
May 12, 2023
USD ($)
robot
Dec. 31, 2025
USD ($)
robot
Oct. 30, 2025
USD ($)
Jun. 16, 2025
USD ($)
Dec. 31, 2024
USD ($)
shares
Jun. 24, 2024
shares
Nov. 30, 2023
USD ($)
Nov. 13, 2023
USD ($)
Commitments and Contingencies (Details) [Line Items]                            
Aggregate principal amount                 $ 1,219,516          
Interest rate               13.50%     5.50%      
Periodic payment               $ 250,000            
Purchase commitment amount, payments made               386,663     $ 82,677      
Excise tax payable               $ 1.2     1      
Promissory Note and Line of Credit Relating to Forbearance Agreement [Member]                            
Commitments and Contingencies (Details) [Line Items]                            
Basis spread on the variable rate         3.00%                  
Debt instrument, variable interest rate, type [Extensible enumeration]         prime rate                  
Interest rate               6.75%            
Payments for forbearance                         $ 80,000 $ 20,000
Periodic payment   $ 100,000 $ 50,000 $ 25,000                    
Periodic payment terms, balloon payment to be paid                   $ 1,541,106        
Purchase Agreement for Telepresence Robots [Member]                            
Commitments and Contingencies (Details) [Line Items]                            
Number of robots purchased (in robot) | robot               20            
Total purchase commitment               $ 711,900            
Unpaid commitment amount               $ 179,900     $ 179,900      
Percentage of monthly revenue generated from telepresence robots, considered for payment             80.00%              
Telepresence robots deployed (in robot) | robot               8            
Total number of deployed telepresence robots (in robot) | robot             11              
Number of robots for which lifetime use payments is to be made (in robot) | robot               125            
Amount paid by investor             $ 352,000              
Equity Incentive Plan 2024 [Member]                            
Commitments and Contingencies (Details) [Line Items]                            
Percentage of shares reserved for issuance               15.00%            
Number of shares issued (in Shares) | shares                     2,544,021 2,544,021    
Investor [Member]                            
Commitments and Contingencies (Details) [Line Items]                            
Number of deployed telepresence robots rights held (in robot) | robot               8            
Percentage of monthly revenue generated from telepresence robots, considered for payment               80.00%            
Investor [Member] | IDoc Virtual Telehealth Solutions, Inc [Member]                            
Commitments and Contingencies (Details) [Line Items]                            
Aggregate principal amount           $ 200,000   $ 200,000            
Number of deployed telepresence robots rights held (in robot)           8                
Percentage of monthly revenue generated from telepresence robots, considered for payment           80.00%                
Telepresence robots deployed (in robot)           8   8            
Subsequent Event [Member]                            
Commitments and Contingencies (Details) [Line Items]                            
Settlement agreement description Subsequent to the balance sheet date, on February 16, 2026, the Company entered into a settlement agreement to fully settle the Encompass Purchase liability for an aggregate amount of $650,000. The settlement consists of (i) a cash payment of $50,000, (ii) issuance of Company shares with an aggregate fair value of $400,000, and (iii) assignment of a loan liability of $200,000.                          
Minimum [Member] | Investor [Member] | IDoc Virtual Telehealth Solutions, Inc [Member]                            
Commitments and Contingencies (Details) [Line Items]                            
Total number of deployed telepresence robots (in robot)           12   13            
Maximum [Member] | Investor [Member] | IDoc Virtual Telehealth Solutions, Inc [Member]                            
Commitments and Contingencies (Details) [Line Items]                            
Total number of deployed telepresence robots (in robot)           20   20